Action 301047 SINO BIOLOGICAL,INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Sino Biological,Inc.

Actions

301047

CNE100004Q23

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 30/04/2024 		Varia. 5j. Varia. 1 janv.
70,51 CNY -0,14% Graphique intraday de Sino Biological,Inc. +2,62% -14,43%
28/04 Sino Biological, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI
26/04 Sino Biological Inc. (SZSE:301047) a conclu l'acquisition de SignalChem Biotech Inc. auprès de Signalchem Lifesciences Corporation. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Sino Biological,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio
Sino Biological,Inc. completed the acquisition of SignalChem Biotech Inc. from Signalchem Lifesciences Corporation.
Sino Biological,Inc. Proposes Final Cash Dividend for the Year 2023
Sino Biological,Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Sino Biological,Inc.'s Equity Buyback Plan announced on February 23, 2024.
Sino Biological Announces Services Partnership with Rapid Novor
Sino Biological,Inc. commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on February 19, 2024.
Bio-Link Pharmaceutical Technology Co., Ltd. announced that it has received funding from Cathay Capital Private Equity SAS, Sino Biological,Inc., Suzhou GSL Venture Capital Management Company, Beijing GSR United Capital Management Consulting Co., Ltd., Tianjin Qianxi Investment Management Partnership Ent. (L.P.), Shanghai Pudong Haiwang Private Fund Management Co., Ltd. and other investors
Sino Biological,Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
Sino Biological to Acquire Canada’s SignalChem Biotech for $48 Million
Sino Biological,Inc. entered into Share Purchase Agreement to acquire SignalChem Biotech Inc. from Signalchem Lifesciences Corporation for CAD 65.85 million.
Sino Biological: new US centre for bioprocessing
Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing
Sino Biological,Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
Certain A Shares of Sino Biological Inc. are subject to a Lock-Up Agreement Ending on 17-AUG-2023.
Sino Biological Unit to Lease Beijing Property to Shenzhou Cell Engineering
Sino Biological Buys Land for 918 Million Yuan
Sino Biological,Inc Approves the Final Cash Dividend for the Year 2022, Payable on 24 May 2023
Sino Biological,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 301047
  4. Actualités Sino Biological,Inc.
  5. Autres langues